Stem cell bioengineered skin
This article was originally published in The Gray Sheet
Executive Summary
U.S. BioDefense, Inc. files for Small Business Innovation Research Grant to support development of its stem-cell technology for the creation of skin grafts to treat skin wounds. The company is focused on the treatment of vesicant-agent-induced cutaneous burns that would result from a mustard gas or other biological weapon attack. The City of Industry, Calif.-based firm is taking advantage of California Proposition 71, which approved an unprecedented $3 bil. investment in stem-cell research funding over the next decade. Wisconsin also is looking to fund stem cell research (1"The Gray Sheet" Nov. 29, 2004, p. 13)...